BCBS ProgressHealth

Visit BCBS.com

5-Min Read

Short on time? If you read nothing else, read this. Explore more 5-Min Reads

Medicare

The skinny on the donut hole

Tobacco

Five reasons why tobacco is still a public health enemy

Issues

Our top priorities, explained.

Addressing the rising cost of healthcare

Why does healthcare cost so much? The price of medical care is the single biggest factor, accounting for 90 percent of spending.

Creating—and sustaining—the innovation that is Medicare

BCBS companies provide coordinated, patient-centered care for millions of Medicare beneficiaries and are making sure it continues to modernize.

Providing access to safe, effective and affordable prescriptions

As prescription drug prices climb, we are working to ensure BCBS members get the medication they need at a price they can afford.

Tackling America's opioid epidemic

BCBS companies are addressing the opioid crisis in communities around the country, ensuring patients get the right care in the right setting.

Supporting and improving Medicaid

BCBS companies provide access to critical health services for millions of adults and children through Medicaid, and are addressing the unique health challenges they face.

Improving the individual market

Healthcare should be available to everyone, no matter who they are or where they live. This starts with improving the individual market.

Insights

Leading voices in healthcare share their ideas.

Prescription Drugs

It’s time to CREATE more choices & lower drug prices

By Chip Davis, President and CEO, Association for Accessible Medicines (AAM)

Biologic drugs are pushing the boundaries of medicine, and their potential to benefit patients with unmet medical needs has never been more promising. For example, researchers are using a viral therapy to treat advanced melanoma by targeting only cancerous cells, and prompting the patient’s immune system to attack them as well.

But all too often these medicines are prohibitively expensive, creating barriers to patient access and limiting their life-saving power. In 2017 alone, spending on biologic medicines hit a record $120 billion and, in the years ahead, this will contribute to a rising percentage of overall healthcare spending.